Radial artery occlusion after aneurysm treatment using the rist guide catheter: Single center cohort study

Julien Allard1, Eimad Shotar1, Kévin Premat1

  • 1Department of Neuroradiology, Sorbonne University, APHP, Pitié-Salpêtrière Hospital, 47, Bd de l'Hôpital, 75013, Paris, France.

Insights

Delayed radial artery occlusion (dRAO) occurred in 27.3% of patients after neurointervention using the RIST 079 guide catheter (RIST GC). This study assessed dRAO rates and risk factors following transradial access for intracranial aneurysm treatment.

Area of Science:

  • Interventional Neuroradiology
  • Vascular Surgery
  • Neuroendovascular Procedures

Background:

  • Delayed radial artery occlusion (dRAO) is a common complication following transradial access (TRA) in neurointervention, particularly with large guide catheters.
  • The RIST 079 guide catheter (RIST GC) represents a novel device specifically engineered for TRA in neurointerventional procedures.

Purpose of the Study:

  • To evaluate the incidence of dRAO after intracranial aneurysm (IA) treatment utilizing the RIST GC via TRA.
  • To identify potential risk factors associated with dRAO in this patient cohort.

Main Methods:

  • A prospective study involving 22 patients who underwent IA treatment using TRA and the RIST GC between June 2021 and November 2022.
  • Systematic US-Doppler assessment of radial artery patency was performed at a 3-month follow-up to detect dRAO.
  • Comparative analysis was conducted between patients with and without dRAO to determine risk factors.

Main Results:

  • At 3-month follow-up, 6 out of 22 patients (27.3%) exhibited dRAO.
  • Among those with dRAO, 4 were asymptomatic, while 2 experienced radial hematoma and wrist pain.
  • A trend towards younger age, longer procedure duration, and increased forearm hematoma was observed in patients with dRAO.
  • Successful navigation with the RIST GC was achieved in 90.9% of cases; complications were linked to left internal carotid artery navigation.

Conclusions:

  • The study found a 27.3% rate of dRAO at 3-month follow-up in patients treated for IA using TRA with the RIST GC.
  • While the RIST GC demonstrated high navigation success, dRAO remains a significant concern requiring further investigation and potential mitigation strategies.
Abstract